| Shasun Pharmaceuticals has reported a consolidated total income from operations of Rs 325.00 crore and a net profit of Rs 6.14 crore for the quarter ended Dec '14. | | For the quarter ended Dec 2013 the consolidated total income from operations was Rs 325.28 crore and net profit was Rs 13.04 crore. | | Shasun Pharma shares closed at 259.90 on February 06, 2015 (BSE) and has given 68.22% returns over the last 6 months and 225.28% over the last 12 months. |
|
| | Shasun Pharmaceuticals | | Consolidated Quarterly Results | -------- in Rs. Cr. -------- |
|
| Dec '14 | Sep '14 | | | Dec '13 | | Net Sales/Income from operations | 310.05 | 306.03 | | | 309.38 | | Other Operating Income | 14.95 | 13.93 | | | 15.90 | | Total Income From Operations | 325.00 | 319.96 | | | 325.28 | | EXPENDITURE | | | | | | | Consumption of Raw Materials | 177.62 | 162.59 | | | 164.09 | | Purchase of Traded Goods | 0.38 | 2.68 | | | 0.94 | | Increase/Decrease in Stocks | -15.23 | 3.96 | | | -8.39 | | Power & Fuel | -- | -- | | | -- | | Employees Cost | 59.56 | 60.79 | | | 58.53 | | Depreciation | 11.76 | 9.98 | | | 14.88 | | Excise Duty | -- | -- | | | -- | | Admin. And Selling Expenses | -- | -- | | | -- | | R & D Expenses | -- | -- | | | -- | | Provisions And Contingencies | -- | -- | | | -- | | Exp. Capitalised | -- | -- | | | -- | | Other Expenses | 69.99 | 70.54 | | | 71.95 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 20.92 | 9.42 | | | 23.28 | | Other Income | 1.58 | 4.26 | | | 3.46 | | P/L Before Int., Excpt. Items & Tax | 22.50 | 13.68 | | | 26.74 | | Interest | 15.69 | 12.36 | | | 13.78 | | P/L Before Exceptional Items & Tax | 6.81 | 1.32 | | | 12.96 | | Exceptional Items | -- | -- | | | -- | | P/L Before Tax | 6.81 | 1.32 | | | 12.96 | | Tax | -- | 0.02 | | | -0.08 | | P/L After Tax from Ordinary Activities | 6.81 | 1.30 | | | 13.04 | | Prior Year Adjustments | -- | -- | | | -- | | Extra Ordinary Items | -- | -- | | | -- | | Net Profit/(Loss) For the Period | 6.81 | 1.30 | | | 13.04 | | Minority Interest | -- | -- | | | -- | | Share Of P/L Of Associates | -0.67 | -1.05 | | | -- | | Net P/L After M.I & Associates | 6.14 | 0.25 | | | 13.04 | | Equity Share Capital | 12.03 | 12.03 | | | 11.33 | | Reserves Excluding Revaluation Reserves | -- | -- | | | -- | | Equity Dividend Rate (%) | -- | -- | | | -- | | EPS Before Extra Ordinary | | | | | | | Basic EPS | 1.02 | 0.04 | | | 2.30 | | Diluted EPS | 0.99 | 0.04 | | | 2.30 | | EPS After Extra Ordinary | | | | | | | Basic EPS | 1.02 | 0.04 | | | 2.30 | | Diluted EPS | 0.99 | 0.04 | | | 2.30 | | Public Share Holding | | | | | | | No Of Shares (Crores) | 3.64 | 3.64 | | | 3.29 | | Share Holding (%) | 60.51 | 60.51 | | | 58.03 | | Promoters and Promoter Group Shareholding | | | | | | | a) Pledged/Encumbered | | | | | | | - Number of shares (Crores) | 0.29 | 0.41 | | | 0.75 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 12.29 | 17.28 | | | 31.72 | | - Per. of shares (as a % of the total Share Cap. of the company) | 4.85 | 6.82 | | | 13.31 | | b) Non-encumbered | | | | | | | - Number of shares (Crores) | 2.08 | 1.96 | | | 1.62 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 87.71 | 82.72 | | | 68.28 | | - Per. of shares (as a % of the total Share Cap. of the company) | 34.64 | 32.67 | | | 28.66 | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
